Valion Bio (VBIO) Assets (QoQ) (2022 - 2025)
Valion Bio (VBIO) Assets (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Valion Bio | 410,331.63 | -1.79 Mn | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 407.42% |
| Sep 30, 2025 | 38.18% |
| Jun 30, 2025 | 19.35% |
| Mar 31, 2025 | 34.56% |
| Dec 31, 2024 | -17.30% |
| Sep 30, 2024 | -29.04% |
| Jun 30, 2024 | 45.56% |
| Mar 31, 2024 | -36.28% |
| Dec 31, 2023 | -26.40% |
| Sep 30, 2023 | 52.46% |
| Jun 30, 2023 | -35.28% |
| Mar 31, 2023 | 20.87% |
| Dec 31, 2022 | -28.42% |
| Sep 30, 2022 | -25.56% |
| Jun 30, 2022 | -13.14% |
| Mar 31, 2022 | -15.58% |